Gordon W. Blair

1.9k total citations
25 papers, 701 citations indexed

About

Gordon W. Blair is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Gordon W. Blair has authored 25 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Neurology. Recurrent topics in Gordon W. Blair's work include Acute Ischemic Stroke Management (14 papers), Cerebrovascular and Carotid Artery Diseases (12 papers) and Neurological Disorders and Treatments (5 papers). Gordon W. Blair is often cited by papers focused on Acute Ischemic Stroke Management (14 papers), Cerebrovascular and Carotid Artery Diseases (12 papers) and Neurological Disorders and Treatments (5 papers). Gordon W. Blair collaborates with scholars based in United Kingdom, Germany and United States. Gordon W. Blair's co-authors include Joanna M. Wardlaw, Fergus Doubal, Michael J. Thrippleton, Ian Marshall, Francesca M. Chappell, Iona Hamilton, Yulu Shi, Hungshu Wang, Gerald J. Goldenberg and David Alexander Dickie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Stroke.

In The Last Decade

Gordon W. Blair

24 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gordon W. Blair United Kingdom	14	243	228	210	153	151	25	701
Erica C. Henning United States	13	129 0.5×	117 0.5×	202 1.0×	180 1.2×	189 1.3×	16	592
May Nour United States	16	231 1.0×	154 0.7×	336 1.6×	153 1.0×	86 0.6×	65	974
Xuguang Gao China	13	147 0.6×	99 0.4×	213 1.0×	131 0.9×	31 0.2×	38	723
Chun‐Qiang Lu China	16	113 0.5×	91 0.4×	72 0.3×	105 0.7×	198 1.3×	33	626
Hidenori Oishi Japan	17	919 3.8×	460 2.0×	219 1.0×	67 0.4×	146 1.0×	128	1.3k
Taku Hoshi Japan	8	75 0.3×	160 0.7×	178 0.8×	100 0.7×	53 0.4×	18	498
Fernando Silva Portugal	11	209 0.9×	130 0.6×	364 1.7×	167 1.1×	38 0.3×	42	724
Sergei Bhatta United States	6	265 1.1×	75 0.3×	180 0.9×	193 1.3×	70 0.5×	6	913
N Yasui Japan	17	466 1.9×	182 0.8×	158 0.8×	88 0.6×	186 1.2×	65	903
Oliver Schmidt Germany	12	412 1.7×	51 0.2×	163 0.8×	188 1.2×	89 0.6×	12	1.1k

Countries citing papers authored by Gordon W. Blair

Since Specialization

Citations

This map shows the geographic impact of Gordon W. Blair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon W. Blair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon W. Blair more than expected).

Fields of papers citing papers by Gordon W. Blair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon W. Blair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon W. Blair. The network helps show where Gordon W. Blair may publish in the future.

Co-authorship network of co-authors of Gordon W. Blair

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon W. Blair. A scholar is included among the top collaborators of Gordon W. Blair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon W. Blair. Gordon W. Blair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blair, Gordon W., Ian J. C. MacCormick, Sarah McGrory, et al.. (2025). Retinal vascular reactivity is associated with white matter hyperintensities and dysfunctional cerebrovascular reactivity in cerebral small vessel disease. Journal of Cerebral Blood Flow & Metabolism. 45(12). 2301–2315.

Stringer, Michael, Daniëlle Kerkhofs, Anna Dewenter, et al.. (2024). Heterogeneity and Penumbra of White Matter Hyperintensities in Small Vessel Diseases Determined by Quantitative MRI. Stroke. 56(1). 128–137. 9 indexed citations

Blair, Gordon W., Jason P. Appleton, Lisa J Woodhouse, et al.. (2024). Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2). Stroke and Vascular Neurology. 9(6). 581–594. 2 indexed citations

Rudilosso, Salvatore, Michael Stringer, Michael J. Thrippleton, et al.. (2023). Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease. Journal of Cerebral Blood Flow & Metabolism. 43(9). 1490–1502. 18 indexed citations

Blair, Gordon W., Michael Stringer, Michael J. Thrippleton, et al.. (2021). Imaging neurovascular, endothelial and structural integrity in preparation to treat small vessel diseases. The INVESTIGATE-SVDs study protocol. Part of the SVDs@Target project. SHILAP Revista de lepidopterología. 2. 100020–100020. 14 indexed citations

Stringer, Michael, Gordon W. Blair, Yulu Shi, et al.. (2021). A Comparison of CVR Magnitude and Delay Assessed at 1.5 and 3T in Patients With Cerebral Small Vessel Disease. Frontiers in Physiology. 12. 644837–644837. 8 indexed citations

Brink, Hilde van den, Anna Kopczak, Jeroen C.W. Siero, et al.. (2021). Zooming in on cerebral small vessel function in small vessel diseases with 7T MRI: Rationale and design of the “ZOOM@SVDs” study. SHILAP Revista de lepidopterología. 2. 100013–100013. 12 indexed citations

McHutchison, Caroline, Gordon W. Blair, Jason P. Appleton, et al.. (2020). Cilostazol for Secondary Prevention of Stroke and Cognitive Decline. Stroke. 51(8). 2374–2385. 53 indexed citations

Wardlaw, Joanna M., Philip M. Bath, Fergus Doubal, et al.. (2020). Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease. European Stroke Journal. 5(3). 297–308. 24 indexed citations

10.

Jochems, Angela C.C., Gordon W. Blair, Michael Stringer, et al.. (2020). Relationship Between Venules and Perivascular Spaces in Sporadic Small Vessel Diseases. Stroke. 51(5). 1503–1506. 26 indexed citations

11.

Appleton, Jason P., Gordon W. Blair, Katie Flaherty, et al.. (2019). Effects of Isosorbide Mononitrate and/or Cilostazol on Hematological Markers, Platelet Function, and Hemodynamics in Patients With Lacunar Ischaemic Stroke: Safety Data From the Lacunar Intervention-1 (LACI-1) Trial. Frontiers in Neurology. 10. 723–723. 7 indexed citations

12.

Thrippleton, Michael J., Gordon W. Blair, Maria C. Valdés-Hernández, et al.. (2019). MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease. International Journal of Molecular Sciences. 20(3). 776–776. 12 indexed citations

13.

Blair, Gordon W., Jason P. Appleton, Katie Flaherty, et al.. (2019). Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial. EClinicalMedicine. 11. 34–43. 34 indexed citations

14.

Shi, Yulu, Michael J. Thrippleton, Gordon W. Blair, et al.. (2018). Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow. Journal of Cerebral Blood Flow & Metabolism. 40(1). 85–99. 92 indexed citations

15.

Blair, Gordon W., Jason P. Appleton, Zhe Kang Law, et al.. (2017). Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination. International Journal of Stroke. 13(5). 530–538. 21 indexed citations

16.

Blair, Gordon W., et al.. (2017). Advanced Neuroimaging of Cerebral Small Vessel Disease. Current Treatment Options in Cardiovascular Medicine. 19(7). 56–56. 53 indexed citations

17.

Thrippleton, Michael J., Yulu Shi, Gordon W. Blair, et al.. (2017). Cerebrovascular Reactivity MRI Protocol - Figures. 1 indexed citations

18.

Thrippleton, Michael J., Yulu Shi, Gordon W. Blair, et al.. (2017). Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing. International Journal of Stroke. 13(2). 195–206. 45 indexed citations

19.

Blair, Gordon W., Fergus Doubal, Michael J. Thrippleton, Ian Marshall, & Joanna M. Wardlaw. (2016). Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review. Journal of Cerebral Blood Flow & Metabolism. 36(5). 833–841. 63 indexed citations

20.

Goldenberg, Gerald J., Hungshu Wang, & Gordon W. Blair. (1986). Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.. PubMed. 46(6). 2978–83. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact